However, the detailed mechanisms through which PNP can modulate the NF-κB signaling pathway and immune functions to mitigate AKI will also need to be investigated in the near future, and we will further optimize the dose and concentration of PNP in order to avoid side effects as far as possible in the near future and pay attention to the indicators of the heart. This evidence concerns the gene NFKB1 and acute kidney injury.